Quick Answer
AXIM BIOTECHNOLOGIES, INC. reported Total Assets of $4.12 million for fiscal year 2023.
AXIM BIOTECHNOLOGIES, INC. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2023 | $4.12M | -2.1% |
| 2022 | $4.21M | -20.9% |
| 2021 | $5.32M | +154.8% |
| 2018 | $2.09M | -4.7% |
| 2017 | $2.19M | +51.3% |
| 2016 | $1.45M | +96.2% |
| 2014 | $738.5K | +1199.6% |
| 2013 | $56.8K | -57.2% |
| 2012 | $132.8K | -3.3% |
| 2011 | $137.3K | — |
| 2010 | $0.00 | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| June 30, 2024 | $3.73M | -12.2% | -5.3% |
| March 31, 2024 | $3.93M | -2.7% | -4.5% |
| December 31, 2023 | $4.12M | -2.1% | +1.9% |
| September 30, 2023 | $4.04M | — | -4.8% |
| June 30, 2023 | $4.25M | -6.1% | +5.0% |
| March 31, 2023 | $4.04M | -20.2% | -4.0% |
| December 31, 2022 | $4.21M | -20.9% | -6.8% |
| June 30, 2022 | $4.52M | -56.3% | -10.7% |
- AXIM BIOTECHNOLOGIES, INC. showed a decrease of -2.1% in Total Assets compared to the prior fiscal year.
- The most recent figure is from AXIM BIOTECHNOLOGIES, INC.’s fiscal year 2023 report (Form 10-K), filed with the SEC on April 16, 2024.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: